Jane Buchan - Jul 14, 2022 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Jane Buchan
Stock symbol
IMMX
Transactions as of
Jul 14, 2022
Transactions value $
$0
Form type
4
Date filed
7/18/2022, 06:05 AM
Previous filing
Jun 28, 2022
Next filing
Nov 29, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Options Award $0 +16K +53.33% $0.00 46K Jul 14, 2022 Common Stock 16K $2.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest monthly over 12 months from date of grant.